Dr Giao L Tran, PHARMACIST | |
5586 W 6200 S, Slc, UT 84118 | |
(801) 968-0108 | |
Not Available |
Full Name | Dr Giao L Tran |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 5586 W 6200 S, Slc, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750664785 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 6374749-1701 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Giao L Tran, PHARMACIST 5586 W 6200 S, Kearns, UT 84118 Ph: (801) 652-6676 | Dr Giao L Tran, PHARMACIST 5586 W 6200 S, Slc, UT 84118 Ph: (801) 968-0108 |
News Archive
GenoMed, Inc., a Next Generation DM™ (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today the launch of its national marketing campaign to improve patient outcomes for diabetes, high blood pressure and emphysema.
Speaker Nancy Pelosi issued the following statement today after the Obama Administration announced new guidance to make it easier for small business owners to take advantage of tax credits in the new health insurance reform law, including clarifying that a small business' substantial tax credit under reform will not be reduced if they also receive a state subsidy, and allowing them to receive tax credits for add-on dental and vision coverage in addition to regular health insurance
Kaiser Health News writer Marilyn Werber Serafini, working in collaboration with The Washington Post, interviews Republican pollster Bill McInturff about the GOP's campaign strategy of promising to repeal and replace the new federal health law.
MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings™ in their randomized, double-blind, placebo-controlled Phase 2b clinical study assessing the efficacy of Serdaxin® in patients with major depressive disorder (MDD).
Scientists from the School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin have made a significant discovery of a new biomarker which may help overcome resistance to newer and more targeted anti-cancer drugs, such as Herceptin, for HER2 positive cancers. These findings may also help the early identification of patients who will benefit more from these treatments.
› Verified 2 days ago
Erika Winegar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1676 E 1300 S, Slc, UT 84105 Phone: 801-582-1999 Fax: 801-582-1270 | |
Ms. Maxine Jan Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Foothill Blvd, Slc, UT 84148 Phone: 801-582-4565 | |
Naida Sehovic, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2332 E 2100 S, Slc, UT 84109 Phone: 801-466-9949 | |
Craig M Aramaki, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Chipeta Way, Slc, UT 84108 Phone: 801-587-3200 | |
Laura Cruz, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 828 S 900 W, Slc, UT 84104 Phone: 801-364-2564 | |
Barbara Joyce Olchek, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 N Medical Dr, A50, Slc, UT 84132 Phone: 801-581-2276 Fax: 801-585-2306 | |
Richard Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 S Redwood Rd, Slc, UT 84104 Phone: 801-974-1447 |